189 related articles for article (PubMed ID: 7490533)
21. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
Hansen L; Hartmann B; Mineo H; Holst JJ
Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
[TBL] [Abstract][Full Text] [Related]
23. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats.
Kok NN; Morgan LM; Williams CM; Roberfroid MB; Thissen JP; Delzenne NM
J Nutr; 1998 Jul; 128(7):1099-103. PubMed ID: 9649591
[TBL] [Abstract][Full Text] [Related]
24. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.
Layer P; Holst JJ; Grandt D; Goebell H
Dig Dis Sci; 1995 May; 40(5):1074-82. PubMed ID: 7729267
[TBL] [Abstract][Full Text] [Related]
25. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V
Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702
[TBL] [Abstract][Full Text] [Related]
26. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
Jia X; Brown JC; Kwok YN; Pederson RA; McIntosh CH
Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187
[TBL] [Abstract][Full Text] [Related]
27. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
[TBL] [Abstract][Full Text] [Related]
28. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation.
Claustre J; Brechet S; Plaisancie P; Chayvialle JA; Cuber JC
J Endocrinol; 1999 Aug; 162(2):271-8. PubMed ID: 10425466
[TBL] [Abstract][Full Text] [Related]
30. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
31. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
32. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
[TBL] [Abstract][Full Text] [Related]
33. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ
Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
36. Effect of GIP and GLP-1 antagonists on insulin release in the rat.
Tseng CC; Zhang XY; Wolfe MM
Am J Physiol; 1999 Jun; 276(6):E1049-54. PubMed ID: 10362617
[TBL] [Abstract][Full Text] [Related]
37. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
Holst JJ
BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
[TBL] [Abstract][Full Text] [Related]
38. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.
Cordier-Bussat M; Bernard C; Levenez F; Klages N; Laser-Ritz B; Philippe J; Chayvialle JA; Cuber JC
Diabetes; 1998 Jul; 47(7):1038-45. PubMed ID: 9648826
[TBL] [Abstract][Full Text] [Related]
39. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
Oben J; Morgan L; Fletcher J; Marks V
J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
[TBL] [Abstract][Full Text] [Related]
40. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
